Table 1 Characteristics of study participation

Sex (females/males)

83/7

44/12

87/13

0.058^a

Positive IgG ANAs (%)

100% (90/90)

57% (32/56)

3% (3/100)

< 0.001^a

Positive HA IgG ANA (%)

71% (64/90)

30% (17/56)

0

< 0.001^a

P₅₀ (P₂₅-P₇₅)

P₅₀ (P₂₅-P₇₅)

P₅₀ (P₂₅-P₇₅)

Age (years)

34 (27–45)

37(31–46)

33 (28–44)

0.071^a

SLEDAI score

14 (10–18)

ND

ND

CXCL1 (pg/mL)^c

1492.86 (735.47–2887.34)

174.23 (17.07–368.40)

13.58 (8.46–37.22)

< 0.001^b

An-dsDNA IgG (IU/L)^d

1093.37 (448.21–2215.30)

10 (10–10)

10 (10–10)

< 0.001^b

C3 (g/L)^e

0.54 (0.34–0.77)

1.04 (0.86–1.27)

1.09 (0.96–1.23)

< 0.001^b

C4 (g/L)^f

0.09 (0.04–0.12)

0.21 (0.15–0.30)

0.255 (0.21–0.30)

< 0.001^b

ESR (mm/h)^g

25.45 (18.13–54.48)

19.5 (10.7–37.3)

12.75 (7.7–21.43)

< 0.001^b

CRP (mg/mL)^h

1.66 (0.67–5.49)

2.31 (0.92–8.20)

0.44 (0.30–0.57)

< 0.001^b

Albumin (g/L)ⁱ

37.65 (30.88–42.80)

41.3 (35.55–44.53)

45.0 (43.30–46.60)

< 0.001^b

Neu (×10⁹)^j

3.73 (2.60–5.65)

3.29 (2.47–5.03)

3.23 (2.55–4.0)

0.030^b